Ji Jung Eun, Lee Jung Min, Choi Jong Min, Choi Young Hwa, Kim Eun Kyung, Chu So Jung, Kim Seok Kyun, Ahn Kyong Hoon, Lee Dong Hoon, Kim Ha Hyung, Han Kyuboem, Kim Dae Kyong
110Department of Environmental & Health Chemistry, Physical Pharmacy Laboratory, College of Pharmacy, Chung-Ang University, Seoul, 156-756 Korea.
Department of Environmental & Health Chemistry, Hanson Biotech Co., Ltd., Daejeon, 305-811 Korea.
Toxicol Res. 2008 Dec;24(4):315-320. doi: 10.5487/TR.2008.24.4.315. Epub 2008 Dec 1.
Recombinant human granulocyte-macrophage colony stimulating factor (hGM-CSF) is a glycoprotein and hematopoietic growth factors that regulates the proliferation of myeloid precursor cells and activates mature granulocytes and macrophages. In a previous study, we reported that hGM-CSF could be produced in transgenic rice cell suspension culture, termed rhGM-CSF. In the present study, we examined the repeated dose toxicity of rhGM-CSF in SD rats. The repeated dose toxicity study was performed at each dose of 50 and 200 µg/kg subcutaneous administration of rhGM-CSF everyday for 28-days period. The results did not show any changes in food and water intake. There were also no significant changes in both body and organ weights between the control and the tested groups. The hematological and blood biochemical parameters were statistically not different in all groups. These results suggest that rhGM-CSF may show no repeated dose toxicity in SD rats under the conditions.
重组人粒细胞-巨噬细胞集落刺激因子(hGM-CSF)是一种糖蛋白和造血生长因子,可调节髓系前体细胞的增殖,并激活成熟的粒细胞和巨噬细胞。在先前的一项研究中,我们报道了hGM-CSF可以在转基因水稻细胞悬浮培养物中产生,称为rhGM-CSF。在本研究中,我们检测了rhGM-CSF对SD大鼠的重复给药毒性。重复给药毒性研究在rhGM-CSF皮下给药剂量为50和200μg/kg,每天给药,持续28天的条件下进行。结果未显示食物和水摄入量有任何变化。对照组和试验组之间的体重和器官重量也没有显著变化。所有组的血液学和血液生化参数在统计学上无差异。这些结果表明,在该条件下rhGM-CSF对SD大鼠可能没有重复给药毒性。